BOSTON SCIENTIFIC LAUNCHES NEW BALLOON CATHETERS DESIGNED TO ADDRESS WIDE VARIETY OF PERIPHERAL INTERVENTION NEEDS
Boston Scientific Corporation June 6 announced that it has received FDA clearance to launch its Sterling Monorail and Over-the-Wire Balloon Dilatation Catheter in the United States. The balloon catheters are available in a broad range of sizes, offering interventionalists superb clinical versatility. Both balloon catheter platforms are engineered for use in the renal and lower extremity arteries, as well as in dialysis fistula. In addition, the Sterling Monorail® Catheter received a specific indication for use in the carotid arteries as both a pre- and post-dilatation balloon.